• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Covidien

Covidien

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Medtronic Buys Developer of Devices to Treat Aneurysms

    Medtronic Buys Developer of Devices to Treat Aneurysms

  2. Research and Markets: Prescription Pain Drugs: Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts

    Research and Markets: Prescription Pain Drugs: Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts

  3. Medtronic to Buy Privately Held Twelve Inc. -- 2nd Update

    Medtronic to Buy Privately Held Twelve Inc. -- 2nd Update

  4. Research and Markets: Wound Closure Products Market 2015-2023 - The Market was Valued at USD 8.75 Billion in 2014

    Research and Markets: Wound Closure Products Market 2015-2023 - The Market was Valued at USD 8.75 Billion in 2014

  5. Check-Cap Announces Appointment of William Densel as Chief Executive Officer and Director

    Check-Cap Announces Appointment of William Densel as Chief Executive Officer and Director

  6. The Reluctant Bulls of 2014

    After a few fits and starts, Tyco is now set to trade under three separate tickers starting July 2. Tyco International will retain the TYC ticker, Tyco Electronics will assume the TEL ticker, and Covidien , the health-care concern, will trade as COV . We'll have a separate analyst covering each; ...

  7. Covidien's Wide-Moat Device Business Positioned Well for Long-Term Growth

    R&D investments and a narrowed focus have widened the firm's competitive advantages.

  8. Covidien's Mallinckrodt Spin-Off Faces Challenging Environment

    Mallinckrodt's lack of scale and weak branded business keep it from earning a moat.

  9. Super-Wide Moat in the Making at Medtronic

    The device maker's planned acquisition of Covidien will make it a force to be reckoned with.

  10. Mallinckrodt to Buy Immunotherapy Firm Therakos

    Mallinckrodt to Buy Immunotherapy Firm Therakos

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.